Y. Shimada et al. / Tetrahedron: Asymmetry 20 (2009) 2802–2808
2807
4.4. Typicalprocedureforthepreparationofthe enantiomerically
pure acetates (S)-1 with lipase PS
4.6.4. Acetate (R)-1d
>99% ee, ½a 2D8
¼ ꢀ5:4 (c 0.99, CHCl3). HPLC conditions: column,
ꢂ
CHIRALCEL AD-H (Daicel Chemical Industries, Ltd); eluent: hexane/
2-propanol = 95/5; flow rate, 0.5 mL/min; 254 nm; temperature,
25 °C; retention time, 47 (R) and 44 (S) min (1d), 119 (S) and 145
(R) min (4d).
To 200-mL Erlenmeyer flask containing 113 mg (0.358 mmol;
sub. concn, 10 mM) of (S)-1a (98% ee) were added 4 mL of i-Pr2O
and 36 mL of 0.1 M phosphate buffer (pH 6.5). To the mixture
was added 31 mg of lipase PS, and the solution was incubated for
24 h at 30 °C. The products were extracted with AcOEt (ꢁ3),
washed with brine and dried over Na2SO4. After evaporation under
reduced pressure, the residue was purified by flash column chro-
matography on silica gel (hexane/AcOEt = 9/1) to give (S)-1a
Acknowledgements
This work was partially supported by a Grant-in-Aid for Scien-
tific Research (No. 21550051) from the Ministry of Education, Cul-
ture, Sports and Science and Technology, Japan. We thank Material
Science Research Center (Meisei university) for NMR analysis.
(>99% ee) as a colourless oil (98.0 mg, 87%); ½a D23
¼ ꢀ16:3 (c 1.26,
ꢂ
CHCl3). The absolute configuration of 1a was confirmed by compar-
ing the specific rotation value with the reported one: ½a D25
¼ ꢀ13:3
ꢂ
(c 0.96, CHCl3), 80% ee.7a
References
The reactions of the other substrates were carried out by the
same procedure.
1. (a) Zhu, X.-M.; He, L.-L.; Yang, G.-L.; Lei, M.; Chen, S.-S.; Yang, J.-S. Synlett 2006,
3510–3512; (b) Guaragna, A.; De Nisco, M.; Pedatella, S.; Palumbo, G.
Tetrahedron: Asymmetry 2006, 17, 2839–2841; (c) Wang, C.; Kunts, D. A.;
Hamlet, T.; Sim, L.; Rose, D. R.; Pinto, B. M. Bioorg. Med. Chem. 2006, 14, 8332–
8340; (d) Ghosh, A. K.; Gong, G. Org. Lett. 2007, 9, 1437–1440; (e)
Chattopadhyay, A.; Vichare, P.; Dhotare, B. Tetrahedron Lett. 2007, 48, 2871–
2873; (f) Martynow, J. G.; Jozwik, J.; Szelejewski, W.; Achmatowicz, O.; Kutner,
A.; Wisniewski, K.; Winiarski, J.; Zegrocka-Stendel, O.; Golebiewski, P. Eur. J.
Org. Chem. 2007, 689–703; (g) Bedore, M. W.; Chang, S.-K.; Paquette, L. A. Org.
Lett. 2007, 9, 513–516; (h) Zhen, A.-B.; Gao, J.; Wu, Y. J. Org. Chem. 2008, 73,
7310–7316; (i) Carreno, M. C.; Hernandez-Torres, G.; Urbano, A.; Colobert, F.
Eur. J. Org. Chem. 2008, 2035–2038.
2. For recent examples, see: (a) El Ashry, E. S. H.; Abdel-Rahman, A.; Rashed, N.;
Awad, L. F.; Rasheed, H. A. Nucleosides Nucleotides Nucleic Acids 2006, 25, 299–
305; (b) Ikura, M.; Nakatani, S.; Yamamoto, S.; Habashita, H.; Sugiura, T.;
Takahashi, K.; Ogawa, K.; Ohno, H.; Nakai, H.; Toda, M. Bioorg. Med. Chem. 2006,
14, 4241–4252; (c) Koo, B.; McDonald, F. E. Org. Lett. 2007, 9, 1737–1740; (d)
Paolucci, C.; Rosini, G. Tetrahedron: Asymmetry 2007, 18, 2923–2946; (e) Kamal,
A.; Ramesh Khanna, G. B.; Krishnaji, T. Helv. Chim. Acta 2008, 90, 1723–1730.
3. For recent examples, see: (a) Masutani, K.; Minowa, T.; Hagiwara, Y.;
Mukaiyama, T. Bull. Chem. Soc. Jpn. 2006, 79, 1106–1117; (b) Miranda, P. O.;
Ramirez, M. A.; Martin, V. S.; Padron, J. I. Org. Lett. 2006, 8, 1633–1636; (c)
Sharma, G. V. M.; Reddy, J. J.; Reddy, K. L. Tetrahedron Lett. 2006, 47, 6531–
6535; (d) Chen, C.-L.; Sparks, S. M.; Martin, S. F. J. Am. Chem. Soc. 2006, 128,
13696–13697; (e) Mohapatra, D. K.; Ramesh, D. K.; Giardello, M. A.; Chorghade,
M. S.; Gurjar, M. K.; Grubbs, R. H. Tetrahedron Lett. 2007, 48, 2621–2625; (f)
Fernandez, C.; Gandara, Z.; Gomez, G.; Covelo, B.; Fall, Y. Tetrahedron Lett. 2007,
48, 2939–2942; (g) Suhara, Y.; Oka, S.; Kittaka, A.; Takayama, H.; Waku, K.;
Sugiura, T. Bioorg. Med. Chem. 2007, 15, 854–867; (h) Sinha, S. C.; Chen, Z.;
Huang, Z.-Z.; Nakamura-Ogiso, E.; Pietraszkiewicz, H.; Edelstein, M.; Valeriote,
F. J. Med. Chem. 2008, 51, 7045–7048.
4. For enzymatic hydrolysis of acyl derivatives of 1,2-diol monotosylates in an
aqueous media, see: (a) Hamaguchi, S.; Ohashi, T.; Watanabe, K. Agric. Biol.
Chem. 1986, 50, 375–380; (b) Hamaguchi, S.; Ohashi, T.; Watanabe, K. Agric.
Biol. Chem. 1986, 50, 1629–1632; (c) Hamaguchi, S.; Katayama, K.; Ohashi, T.;
Watanabe, K. JP 62158250, 1987.; (d) Hamaguchi, S.; Kobayashi, M.; Katayama,
K.; Ohashi, T.; Watanabe, K. JP 62209049, 1987.; (e) Kobayashi, M.; Hamaguchi,
S.; Katayama, K.; Ohashi, T.; Watanabe, K. JP 62212382, 1987.; (f) Pederson, R.
L.; Liu, K. K.-C.; Rutan, J. F.; Chen, L.; Wong, C.-H. J. Org. Chem. 1990, 55, 4897–
4901; (g) Chen, C.-S.; Liu, Y.-C.; Marsella, M. J. Chem. Soc., Perkin Trans. 1 1990,
2559–2561.
5. For enzymatic esterification of 1,2-diol monotosylates in an organic solvent,
see: (a) Chen, C.-S.; Liu, Y.-C. Tetrahedron Lett. 1989, 30, 7165–7168; (b)
Chênevert, R.; Gagnon, R. J. Org. Chem. 1993, 58, 1054–1057; (c) Neagu, C.; Hase,
T. Tetrahedron Lett. 1993, 34, 1629–1630; (d) Boaz, N. W.; Zimmerman, R. L.
Teatrahedron: Asymmetry 1994, 5, 153–156; (e) Boaz, N. W.; Falling, S. N.;
Moore, M. K. Synlett 2005, 1615–1617. For enzymatic hydrolysis in an organic
solvent, see: Ref. 5c For enzymatic alcoholysis in an organic solvent, see: Refs.
5a,4g..
4.5. Transformation of (S)-1a to (S)-4a
Under an argon atmosphere, to a solution of (S)-1a (>99% ee,
179 mg, 0.568 mmol) in THF (4 mL) were added DIBAL-H (2.3 mL,
1.0 M toluene solution) at ꢀ78 °C. After the mixture was stirred
for 1.5 h, the reaction was stopped with 0.1 M phosphate buffer
(pH 6.5). The products were extracted with CH2Cl2 (ꢁ3), and the
organic layer was washed with brine and dried over Na2SO4. After
evaporation under reduced pressure, the residue was purified by
flash column chromatography on silica gel (hexane/AcOEt = 6/1)
to give (S)-4a (>99% ee) as a colourless oil (155 mg, 99%);
½
a 2D7
ꢂ
¼ þ8:5 (c 1.08, CHCl3).
4.6. Data for the compounds
4.6.1. Benzoate (S)-9
99% ee, ½a 2D5
¼ þ11:6 (c 1.01, CHCl3). The absolute configuration
ꢂ
of 9 was confirmed by comparing the specific rotation value with
an authentic sample prepared from (R)-4a with DCC, DMAP and
benzoic acid: ½a D22
¼ ꢀ14:1 (c 1.00, CHCl3), 99% ee, (R)-form. HPLC
ꢂ
conditions: column, CHIRALCEL AD-H (Daicel Chemical Industries,
Ltd); eluent: hexane/2-propanol = 95/5; flow rate, 0.5 mL/min;
254 nm; temperature, 25 °C; retention time, 35 (S) and 48 (R) min.
IR (neat); 2955, 2932, 2860, 1719, 1362, 1177, 914 and 733 cmꢀ1
;
1H NMR (300 MHz, CDCl3) d = 0.87 (t, J = 6.5 Hz, 3H), 1.18–1.41 (m,
4H), 1.59–1.85 (m, 2H), 2.36 (s, 3H), 4.19 (dd, J1 = 5.0 Hz,
J2 = 11.0 Hz, 1H), 4.24 (dd, J1 = 3.5 Hz, J2 = 11.0 Hz, 1H), 5.15–5.24
(m, 1H), 7.21 (d, J = 8.5 Hz, 2H), 7.38–7.47 (m, 2H), 7.54–7.62 (m,
2H), 7.71–7.78 (m, 2H), 7.90–7.97 (m, 2H); 13C NMR (75 MHz, CDCl3)
d = 13.8, 21.6, 22.4, 27.1, 30.0, 70.1, 71.5, 127.9, 128.3, 129.7, 129.8,
133.1, 144.8, 165.7, 181.9; MS m/z (rel intensities) 376 (M+, 1.2%),
254 (3.2), 155 (15), 105 (100), 91 (33), 78 (43); HRMS m/z
376.1345 (376.1344 calcd for C20H24O5S, M+).
4.6.2. Acetate (S)-1b
>99% ee, ½a 2D9
¼ ꢀ13:5 (c 1.35, CHCl3). HPLC conditions: column,
ꢂ
6. For enantioselective decomposition of 1,2-diol monotosylates by
microorganisms, see: Saito, Y.; Nakamura, T. JP 10057096, 1998.
CHIRALCEL AD-H (Daicel Chemical Industries, Ltd); eluent: hexane/
2-propanol = 98/2; flow rate, 0.5 mL/min; 254 nm; temperature,
25 °C; retention time, 63 (S) and 59 (R) min (1b): eluent: hexane/
2-propanol = 95/5, 82 (R) and 100 (S) min (4b).
7. (a) Shimada, Y.; Sato, H.; Minowa, S.; Matsumoto, K. Synlett 2008, 367–370; (b)
Shimada, Y.; Sato, H.; Mochizuki, S.; Matsumoto, K. Synlett 2008, 2981–2984.
8. For recent examples, see: (a) Bogár, K.; Martin-Matute, B.; Bäckvall, J.-E.
Beilstein J. Org. Chem. 2007, 3, 50; (b) Strubing, D.; Krumlinde, P.; Piera, J.;
Bäckvall, J.-E. Adv. Synth. Catal. 2007, 349, 1577–1581; (c) Parvulescu, A. N.;
Jacobs, P. A.; De Vos, D. E. Adv. Synth. Catal. 2008, 350, 113–121; (d) Kim, M.-J.;
Choi, Y. K.; Kim, S.; Kim, D.; Han, K.; Ko, S.-B.; Park, J. Org. Lett. 2008, 10, 1295–
1298; (e) Han, K.; Park, J.; Kim, M.-J. J. Org. Chem. 2008, 73, 4302–4304; (f) Ahn,
Y.; Ko, S.-B.; Kim, M.-J.; Park, J. Coord. Chem. Rev. 2008, 252, 647–658; (g) Haak,
R. M.; Berthiol, F.; Jerphagnon, T.; Gayet, A. J. A.; Tarabiono, C.; Postema, C. P.;
Ritleng, V.; Pfeffer, M.; Janssen, D. B.; Minnaard, A. J.; Feringa, B. L.; de Vries, J. G.
J. Am. Chem. Soc. 2008, 130, 13508–13509.
4.6.3. Acetate (S)-1c
>99% ee, ½a 2D7
¼ þ4:6 (c 1.46, CHCl3). HPLC conditions: column,
ꢂ
CHIRALCEL AD-H (Daicel Chemical Industries, Ltd); eluent: hexane/
2-propanol = 90/10; flow rate, 0.5 mL/min; 254 nm; temperature,
25 °C; retention time, 56 (S) and 68 (R) min (1c), 93 (R) and 107
(S) min (4c).
9. Mitsunobu, O. Synthesis 1981, 1–28.